Four Democratic-led US states urge FDA to remove abortion pill restrictions
NEW YORK, June 5 (Reuters) - The attorneys general of New York, California, Massachusetts and New Jersey asked the Food and Drug Administration to expand access to the abortion pill mifepristone, and remove what they view as outdated and medically unnecessary restrictions.
Thursday's petition by the Democratic-led states seeks to force the FDA to acknowledge what the states view as "extensive" evidence that mifepristone is safe, notwithstanding the Trump administration's general opposition to abortion.
It came after Health and Human Services Secretary Robert F. Kennedy Jr told Congress last month he ordered FDA Commissioner Marty Makary to review the pill, and unspecified "alarming" new data suggested the government should at least change the label.
Mifepristone is the first pill, followed by the drug misoprostol, for medication abortion in the first 10 weeks of pregnancy, and won FDA approval in 2000.
Medication abortions account for more than half of U.S. abortions, though 28 states restrict access, according to the nonprofit Guttmacher Institute, which focuses on reproductive health.
The petition challenges FDA requirements that mifepristone prescribers be included in national and local abortion provider lists, patients attest in writing that they intend to end their pregnancies, and pharmacies perform a variety of recordkeeping.
Citing the drug's safety record, it said those rules, part of the FDA's Risk Evaluation and Mitigation Strategy program, are "no longer justified by science or law," especially in states where abortion is legal and comprehensively regulated.
New York Attorney General Letitia James said the rules keep mifepristone out of reach of most primary care settings. She called that problem particularly acute in rural and other areas where getting abortions often requires lengthy travel.
"There is simply no scientific or medical reason to subject it to such extraordinary restrictions," James said, referring to mifepristone. "The FDA must follow the science."
A spokeswoman for the Department of Health and Human Services said FDA Commissioner Makary "will ensure gold standard science is used while incorporating practical, common-sense considerations to its regulatory processes."
Many states, primarily Republican-led or leaning, have restricted or substantially eliminated abortions in the three years since the U.S. Supreme Court overturned Roe v. Wade, the 1973 decision that legalized the procedure nationwide.
Last June, the Supreme Court preserved broad access to mifepristone, unanimously ruling that a group of anti-abortion organizations and doctors lacked legal standing to challenge the FDA's approval of the pill.
Despite largely siding with abortion opponents, Republican President Donald Trump said during his 2024 campaign he did not plan to limit access to mifepristone.
Last month, the administration asked a federal judge to dismiss, on procedural grounds, a lawsuit by three generally Republican states seeking to narrow such access.
That lawsuit began during the administration of Democratic President Joe Biden, who generally supported abortion access.
Seventeen other Democratic-led or -leaning states plus Washington, D.C., are separately suing the FDA in Spokane, Washington, to loosen restrictions on mifepristone.
They said doctors and pharmacies should be able to dispense the pill, as with most drugs, without special certifications.
On May 30, the Trump administration urged a dismissal, saying the states didn't show the FDA's policy was flawed or the agency ignored important evidence.
The states filed Thursday's petition after a short delay, with the filing having been expected earlier in the morning.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
an hour ago
- Telegraph
This is a sector to buy when the news is bad
Questor is The Telegraph's stock-picking column, helping you decode the markets and offering insights on where to invest. It has proved a turbulent year so far for United Airlines, the world's biggest airline by available seat miles. Such is the economic uncertainty created by Trump's tariffs that when the company's forthright chief executive, Scott Kirby, released earnings guidance earlier this year, he made the unusual decision of presenting two scenarios. On a stable economic outlook, he reckoned New York-listed United could deliver earnings per share (EPS) of between $11.50 and $13.50. However, if the big policy moves from the White House triggered a recession, he told shareholders to expect something more like $7 to $9. It's not only economic policy that has been causing Kirby planning headaches this year. United is the biggest operator at Newark Liberty International Airport, which it uses as its New York base for flights, but the airport has been experiencing problems with air traffic control, including a high-profile outage in late April. Not only have the issues caused delays and cancellations of flights, safety concerns are also hitting demand. United has said the problems will weigh on financial performance this year, although, it has not quantified this. And then there's the oil price. While oil has been weak for some time, heightened tensions in the Middle East raise concerns United, along with its peers, could face higher fuel prices, which represents a key cost for airlines. It is the propensity for airlines to frequently encounter highly consequential and extremely unpredictable events, coupled with their high fixed costs, which makes the sector uninvestible for many. However, for those who dare, this is a sector to buy when the news is bad. Indeed, the valuation of United shares at 6.6 times next-year forecast earnings illustrates the lure of this strategy, given its valuation looks much more attractive than its closest peers – which are Delta Airlines valued at 7.8 times, American Airlines on 7.3, and Southwest on 17.5. Many of the world's best fund managers see merit in the stock at the current price. Financial publisher, Citywire, which rates stocks based on their ownership by the top 3pc of equity managers globally, has raised United's Elite Companies rating from A to a top AAA this month on increased backing by the elite investors it follows. A total of nine hold the shares. Beyond the negative recent news flow, there are reasons to be optimistic about United's prospects. For one thing, United is one of the most profitable companies in its sector. Despite weak demand felt across the industry in the first quarter, United was one of only two airlines to report a profit for the period, and its 3.6pc pre-tax profit margin was its best result for the traditionally softer quarter since before the pandemic. The response to weak demand from across the industry should help shore up profitability. United has announced a capacity cut of 4pc and many rivals are taking similar measures. Fewer seats in the sky generally means fuller planes and higher ticket prices. The problems at Newark could soon start to ease, too. Some of the issues have been associated with the construction of a new runway, which was completed at the start of June. Kirby has said that with the runway open and planned flight limits implemented, he expects Newark to be the most reliable airport in the New York area from this summer. From a longer-term perspective, United is aiming to boost the efficiency of its fleet while attracting high-value passengers. Key to efficiency gains are plans to take delivery of 660 new aircraft by 2033, with a strategic switch from Boeing to Airbus planes, and the new fleet will help to differentiate between its offerings. Differentiating services is key to boosting higher-margin premium travel. Already efforts such as the roll out of Starlink powered WiFi on flights are helping. Premium revenue was up 9.2pc in the first quarter, and the group is also broadening its offering of international flights, which are more profitable. While we certainly live in uncertain times, for now brokers forecast EPS that's closer to United's 'stable' than 'recession' guidance. Airlines are always a risky bet, but many of the world's best fund managers like the odds offered by United's shares. United's shares can be bought though all major UK dealing platforms, but Brits should check for any extra charges, and while United does not pay a dividend, documents to minimise withholding tax should be completed.
Reuters
2 hours ago
- Reuters
Insight: How middlemen funnel illegal Chinese vapes into the United States
LONDON/NEW YORK/CHICAGO, June 23 (Reuters) - From an office a 15-minute drive from Chicago's O'Hare International Airport, one small firm helped import millions of unauthorized Chinese-made vapes last year alone, forming a key link in the supply chain feeding U.S. demand for illegal e-cigarettes. In a little over four years, the firm, a customs brokerage run by a man named Jay Kim, became a go-to broker for the Chinese vape industry. The firm worked on 60% of all shipments of vapes and vape parts from China to the U.S. in 2024 registered by the Food and Drug Administration, according to a Reuters analysis. "A lot of them have FDA authorization," Kim said in an interview in his office in April, referring to the vape shipments his firm handled. However, FDA data on imports into the U.S. of FDA-regulated goods such as tobacco products or medicines showed the products Kim's firm helped bring into the United States included unauthorized brands like Lost Mary and Geek Bar. The FDA has declared those brands illegal to import or sell, warning their array of fruit and candy flavors may appeal to children. The agency says nicotine can harm developing brains, and impact attention, learning and mood in young people, who can get hooked more easily on the addictive chemical. A Lost Mary spokesperson said it had no connection or contact with Kim's firm, and flavors play a key role in helping adult users quit smoking. The maker of Geek Bar did not respond to a request for comment. The Chinese city of Shenzhen is the biggest source of vapes, both legal and illegal, coming into the United States. In 2024, China exported more than 26 billion yuan ($3.6 billion) in vapes to the U.S., according to Chinese customs data. But U.S. customs figures show only $333 million in Chinese vapes were officially received in the U.S. that same year. Mismatches in custom data between the U.S. and its trading partners are not uncommon, but a 90% gap was unusual, two customs data specialists told Reuters. Unauthorized vapes often arrive in the U.S. disguised as other items like shoes and toys, according to the FDA, which leads efforts to control the vape market. Reuters used FDA and U.S. customs data, interviews with vape and tobacco industry insiders, and information from U.S. regulators and law enforcement to build a picture of how unauthorized vapes make their way onto U.S. shelves. It found a group of middlemen based on U.S. soil - including some customs brokers and distributors - who played key roles in the vape supply chain, and sometimes take steps to avoid detection. Trump Administration officials have promised a crackdown; FDA Commissioner Marty Makary has said the agency will stop illegal imports and distribution. "Our borders have been far too porous when it comes to challenges like illegal e-cigarette products coming from other countries," an FDA spokesperson said, adding that the agency is planning to use artificial intelligence to "stem the flow of products that are appealing to our nation's children." In May, the FDA and Customs and Border Protection announced a $34 million seizure of unauthorized vapes in Chicago. Officials found many of the shipments in the seizure, which took place in February, contained vague product descriptions and incorrect values. As part of the operation, for the first time, the agency sent letters to 24 middlemen involved in the vape supply chain, including U.S. importers and customs brokers. The letters warned the middlemen it was a crime to make false statements to the government, and asked them to explain how they ensured they followed tobacco laws, according to the FDA. Reuters was not able to establish whether Kim was among the customs brokers who received a letter from the FDA. He did not respond to detailed questions about Reuters' findings. Customs brokers do not buy or sell goods themselves. Rather, they are paid by others, usually the importer, to help navigate the customs process by submitting documents and fielding enquiries from border officials, according to Lenny Feldman, a managing partner at the law firm Sandler, Travis & Rosenberg. Customs brokers may be breaking the law if they are found to have not conducted proper due diligence, said Feldman. Speaking briefly to Reuters at his office in April, Kim said his firm did not deal with vape shipments anymore after exiting the business last year. He said that a former employee of his firm had gotten him into working with vape clients and took those customers with her when she left. However, the FDA data reviewed by Reuters showed that vape-related shipments handled by Kim have continued throughout 2025, including in June. The FDA, which was directed to fire 3,500 employees in March, works with CBP to catch unauthorized vape shipments at the border. A spokesperson for CBP told Reuters the agency seized over 3 million units of illegal vapes valued at $76 million in 2024. 'CBP has encountered bad actors exploiting shipments to transit illicit goods, including illegal vapes, synthetic opioids, precursor chemicals and related paraphernalia,' the spokesperson said. The FDA said that over the past two years, efforts by FDA and CBP had led to the seizure of around 7.1 million e-cigarettes with an estimated retail value of over $136 million. Secretary of Health and Human Services Robert F. Kennedy Jr. said the administration would "wipe out" fruity and sweet flavored vapes from China that appeal to kids. "We are going to get rid of all of them," he told the Senate Committee on Health, Education, Labor and Pensions in May. Illinois Congressman Raja Krishnamoorthi said middlemen like Kim bear some responsibility for the flood of vapes, but lays most of the blame with the FDA, which he accuses of sitting idle while illegal vapes flood into the country. "The FDA is a disaster. It's asleep at the switch," he said. "You have illicit vapes all over the place." The Trump Administration's tariffs on China, as well as vape seizures, have already dented supply, Reuters reported this month. Vape shipments recorded by the FDA collapsed in May, with a shortage of popular brand Geek Bar in particular. The FDA has authorized 34 different vape products made by companies like British American Tobacco (BATS.L), opens new tab and Altria (MO.N), opens new tab, but no fruity or sweet flavored vapes that the FDA says could appeal to children. And yet executives at BAT estimate unauthorized devices make up 70% of vape sales in the U.S., valuing their sales at $8.14 billion last year. The supply chain ferrying illegal Chinese-made vapes into the U.S. mostly operates in plain sight. It starts with a network of exporters based in China. After a vape shipment clears customs in the U.S., it is passed along to its U.S. buyer - usually a distributor, which then sells them to smaller wholesalers and retailers nationwide. The FDA collects data on U.S.-based recipients of vape shipments. The largest in 2024 was Reynolds American, the U.S. subsidiary of BAT. But the top ten largest U.S. vape recipients also included six obscure firms, opened in 2023 or 2024 and sometimes operating out of residential homes. The second-largest recipient of vape shipments in 2024 was a Chicago-based company called Somo Trade LLC, established in 2023, Reuters analysis of FDA data and state business filings show. A woman at the business' address, a residential home on Chicago's north side, told a Reuters reporter that the property was not involved in the vape business. Another recipient of vapes, Rongda Trade, is registered to a house on the same street as Somo Trade, opened the same month, and has already been shut down, its filings show. No one answered the door when Reuters visited the address. No one answered at a residential address linked to Lila Trade on Chicago's southwest side, either. The name of the registered agent, Xiaohong Dai, was not among those listed on four mailboxes out front. Reuters could not find websites for any of the firms, and their state business filings did not contain any contact information. Meanwhile, in February, New York Attorney General Letitia James sued 13 different companies which she said were major U.S. vape distributors, accusing them of working closely with Chinese manufacturers to fuel the unauthorized vape industry. "Together, Defendants have established an industry for flavored e-cigarettes, particularly disposable vapes, and staked out their own lucrative shares in the soaring market," the complaint states. "All have engaged in reprehensible, illegal conduct and aim to addict youth to their products." Mitch Zeller, former head of the FDA's Center for Tobacco Products during the Obama, Trump and Biden administrations, placed the blame on U.S.-based distributors, such as those named in James' lawsuit, for feeding demand. "There's only a handful of middlemen, middle companies, that are responsible for taking the illegal, imported stuff being misclassified and mislabeled and getting it into interstate commerce," he said. ($1 = 7.1836 Chinese yuan renminbi) ($1 = 0.7374 pounds)
The Guardian
2 hours ago
- The Guardian
Palestinian rights activist Mahmoud Khalil and his supporters rally in NYC after release
Freed from Ice detention days earlier, Palestinian rights activist Mahmoud Khalil stood just outside the gates of Columbia University to renew his commitment to the cause of Palestinian freedom and opposition to both the university and the Trump administration. During a speech to the crowd, Khalil took aim at the 'shameful board of trustees at Colombia University', adding that they were 'attempting to expel 15 more students and to suspend tens of others, basically stealing their future, their degrees, their labor, merely because these students are not afraid'
